Search This Blog

Wednesday, November 7, 2018

Vanda Pharmaceuticals reports Q3 EPS 13c, consensus (3c)


Reports Q3 revenue $49.14M, consensus $49.44M.
https://thefly.com/landingPageNews.php?id=2819889
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)